Price Alert

Guardian Pharmacy Service... (GRDN)

NYSE: GRDN · Real-Time Price · USD

28.20

-0.27 (-0.95%)

At close: Sep 05, 2025, 3:59 PM

28.21

0.04%

After-hours: Sep 05, 2025, 05:05 PM EDT

Guardian Pharmacy Services Statistics

Share Statistics

Guardian Pharmacy Services has 63.36M shares outstanding. The number of shares has increased by null% in one year.

Shares Outstanding	63.36M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Institutions (%)	16.51%
Shares Floating	n/a
Failed to Deliver (FTD) Shares	63
FTD / Avg. Volume	0.03%

Short Selling Information

The latest short interest is 496.82K, so 0.78% of the outstanding shares have been sold short.

Short Interest	496.82K
Short % of Shares Out	0.78%
Short % of Float	3.94%
Short Ratio (days to cover)	2.24

Valuation Ratios

The PE ratio is -14.39 and the forward PE ratio is 27.37. Guardian Pharmacy Services's PEG ratio is 0.03.

PE Ratio	-14.39
Forward PE	27.37
PS Ratio	1.02
Forward PS	1.2
PB Ratio	8.81
P/FCF Ratio	30.2
PEG Ratio	0.03

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Guardian Pharmacy Services.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.21.

Current Ratio	1.05
Quick Ratio	0.77
Debt / Equity	0.21
Debt / EBITDA	-0.69
Debt / FCF	0.72
Interest Coverage	-19.19

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$361.3K
Profits Per Employee	$-25.67K
Employee Count	3,400
Asset Turnover	3.83
Inventory Turnover	24.27

Taxes

Income Tax	4.56M
Effective Tax Rate	-6.85%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 1.09, so Guardian Pharmacy Services's price volatility has been higher than the market average.

Beta	1.09
52-Week Price Change	n/a
50-Day Moving Average	22.51
200-Day Moving Average	22.03
Relative Strength Index (RSI)	76.52
Average Volume (20 Days)	240,943

Income Statement

In the last 12 months, Guardian Pharmacy Services had revenue of 1.23B and earned -87.29M in profits. Earnings per share was -1.77.

Revenue	1.23B
Gross Profit	244.37M
Operating Income	-62.92M
Net Income	-87.29M
EBITDA	-43.43M
EBIT	-63.2M
Earnings Per Share (EPS)	-1.77

Full Income Statement

Balance Sheet

The company has 4.66M in cash and 30.13M in debt, giving a net cash position of -25.47M.

Cash & Cash Equivalents	4.66M
Total Debt	30.13M
Net Cash	-25.47M
Retained Earnings	17.12M
Total Assets	356.33M
Working Capital	26.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 57.96M and capital expenditures -16.37M, giving a free cash flow of 41.59M.

Operating Cash Flow	57.96M
Capital Expenditures	-16.37M
Free Cash Flow	41.59M
FCF Per Share	0.67

Full Cash Flow Statement

Margins

Gross margin is 19.89%, with operating and profit margins of -5.12% and -7.11%.

Gross Margin	19.89%
Operating Margin	-5.12%
Pretax Margin	-5.41%
Profit Margin	-7.11%
EBITDA Margin	-3.54%
EBIT Margin	-5.12%
FCF Margin	3.39%

Dividends & Yields

GRDN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for GRDN is $24.5, which is -13.1% lower than the current price. The consensus rating is "Strong Buy".

Price Target	$24.5
Price Target Difference	-13.1%
Analyst Consensus	Strong Buy
Analyst Count	2

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	9.29
Piotroski F-Score	5